Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi NEW YORK–(BUSINESS WIRE)–Dec. 29, 2020– Eyenovia, Inc. (NASDAQ: EYEN), a
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok